The influence of antihypertensive drug treatment on the prevention and regression of left ventricular hypertrophy

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Cardiovascular Research

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0008-6363(99)00291-6
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Fosinopril reduces left ventricular mass in untreated hypertensive patients: a controlled trial.

  1999cited by this paper
• Angiotensin II receptor blockade and end-organ protection: pharmacological rationale and evidence.

  1998cited by this paper
• Effects of nitrendipine and enalapril on left ventricular mass in patients with non‐insulin‐dependent diabetes mellitus and hypertension

  1998cited by this paper
• Cardiac and vascular responses after monocrotaline-induced hypertrophy in rats.

  1998cited by this paper
• Microvasculature in angiotensin II-dependent cardiac hypertrophy in the rat.

  1998cited by this paper
• Reduction of cardiovascular structural changes by nifedipine GITS in essential hypertensive patients.

  1998cited by this paper
• Chronic effects of enalapril and amlodipine on cardiac remodeling in cardiomyopathic hamster hearts.

  1998cited by this paper
• Sodium‐lithium countertransport: physiology and function

  1998cited by this paper
• Enalapril induces regression of cardiac hypertrophy and normalization of pHi regulatory mechanisms.

  1998cited by this paper
• Alterations in calcium handling in cardiac hypertrophy and heart failure.

  1998cited by this paper
• Effects of quinapril, losartan and hydralazine on cardiac hypertrophy and β‐adrenergic neuroeffector mechanisms in transgenic (mREN2)27 rats

  1998cited by this paper
• Do antihypertensive drugs differ in their ability to regress left ventricular hypertrophy?

  1997cited by this paper
• Angiotensin II subtype-1 receptor blockade during the development of left ventricular hypertrophy in dogs: effects on ventricular and myocyte function.

  1997cited by this paper
• Increased left-ventricular mass after losartan treatment.

  1997cited by this paper
• Heart rate and the cardiovascular risk

  1997cited by this paper
• Pressure overload per se rather than cardiac angiotensin converting enzyme activity may be important in the development of rat cardiac hypertrophy

  1997cited by this paper
• Centrally acting antihypertensives: a renaissance of interest. Mechanisms and haemodynamics.

  1997cited by this paper
• Effect of single-drug therapy on reduction of left atrial size in mild to moderate hypertension: comparison of six antihypertensive agents.

  1997cited by this paper
• The Cardiac β-Adrenoceptor–Mediated Signaling Pathway and Its Alterations in Hypertensive Heart Disease

  1997cited by this paper
• Impact of a Low-Dose Reserpine/Thiazide Combination on Left Ventricular Hypertrophy Assessed with Magnetic Resonance Tomography and Echocardiography

  1997cited by this paper
• Effects of long‐term antihypertensive treatment with lisinopril on resistance arteries in hypertensive patients with left ventricular hypertrophy

  1997cited by this paper
• Centrally acting antihypertensives: a renaissance of interest˙ Mechanisms and haemodynamics

  1997cited by this paper
• Chronic endothelin receptor blockade attenuates progressive ventricular dilation and improves cardiac function in rats with myocardial infarction: possible involvement of myocardial endothelin system in ventricular remodeling.

  1997cited by this paper
• Effects of ACE inhibitors versus calcium antagonists on left ventricular morphology and function in patients with essential hypertension.

  1997cited by this paper
• Enalapril and losartan reduced cardiac mass and improved coronary hemodynamics in SHR.

  1997cited by this paper
• Angiotensin-converting enzyme inhibition and angiotensin II subtype-1 receptor blockade during the progression of left ventricular dysfunction: differential effects on myocyte contractile processes.

  1997influential reference
• Effect of single-drug therapy on reduction of left ventricular mass in mild to moderate hypertension: comparison of six antihypertensive agents. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.

  1997cited by this paper
• Angiotensin AT1 receptor inhibition. Effects on hypertrophic remodeling and ACE expression in rats with pressure-overload hypertrophy due to ascending aortic stenosis.

  1997cited by this paper
• Prevention of cardiac hypertrophy by a sub-antihypertensive dose of the alpha 1-adrenergic antagonist bunazosin in Dahl salt-sensitive rats.

  1996cited by this paper
• Influence of isradipine and spirapril on left ventricular hypertrophy and resistance arteries.

  1996cited by this paper
• The efficacy of felodipine ER on regression of left ventricular hypertrophy in patients with primary hypertension.

  1996cited by this paper
• Advanced hypertensive heart disease in spontaneously hypertensive rats. Lisinopril-mediated regression of myocardial fibrosis.

  1996cited by this paper
• Molecular effects of M17055, furosemide and thiazide on cardiac hypertrophy of spontaneously hypertensive rats.

  1996cited by this paper
• Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies.

  1996cited by this paper
• Lisinopril reverses left ventricular hypertrophy through improved aortic compliance.

  1996cited by this paper
• Interrelationships between salt and fish oil in stroke-prone spontaneously hypertensive rat.

  1996cited by this paper
• Cardiac transplantation, perindopril, and left ventricular hypertrophy in spontaneously hypertensive rats.

  1996cited by this paper
• Pharmacology of cardiac and vascular remodeling.

  1995cited by this paper
• Comparison of five antihypertensive monotherapies and placebo for change in left ventricular mass in patients receiving nutritional-hygienic therapy in the Treatment of Mild Hypertension Study (TOMHS).

  1995cited by this paper
• Magnetic resonance imaging of the heart and its role in current cardiology.

  1995cited by this paper
• Structural remodeling in hypertensive heart disease and the role of hormones.

  1994cited by this paper
• Chronic administration of angiotensin II receptor antagonist, TCV-116, in cardiomyopathic hamsters.

  1994cited by this paper
• Magnetic resonance imaging.

  1994cited by this paper
• Morphology of the "athlete's heart" assessed by echocardiography in 947 elite athletes representing 27 sports.

  1994cited by this paper
• Measurement of left ventricular mass in hypertrophic cardiomyopathy using MRI: comparison with echocardiography.

  1993cited by this paper
• Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension.

  1992cited by this paper
• Depressed inotropic response to beta-adrenoceptor agonists in the presence of advanced cardiac hypertrophy in hearts from rats with induced aortic stenosis and from spontaneously hypertensive rats

  1992cited by this paper
• Effects of Nifedipine and Moxonidine on Cardiac Structure in Spontaneously Hypertensive Rats

  1992cited by this paper
• Impaired inotropic response to alpha 1- but not to beta-adrenoceptor stimulation in isolated hearts from spontaneously hypertensive rats.

  1992cited by this paper
• The heart in hypertension.

  1992cited by this paper
• The heart in hypertension.

  1991cited by this paper
• Regression of Cardiovascular Structural Changes After Long‐Term Antihypertensive Treatment with the Calcium Antagonist Nitrendipine

  1991cited by this paper
• Converting enzyme inhibitors regressed cardiac hypertrophy and reduced tissue angiotensin II in spontaneously hypertensive rats.

  1991cited by this paper
• Effects of nifedipine and moxonidine on cardiac structure in spontaneously hypertensive rats (SHR)--stereological studies on myocytes, capillaries, arteries, and cardiac interstitium.

  1991cited by this paper
• "Further studies...".

  1991cited by this paper
• Incidence of sudden cardiac death associated with coronary artery occlusion in dogs with hypertension and left ventricular hypertrophy is reduced by chronic beta-adrenergic blockade.

  1990cited by this paper
• Influence of left ventricular and coronary vascular hypertrophy on cardiac performance.

  1990cited by this paper
• Effects of verapamil and carbon monoxide on blood pressure and heart mass in the spontaneously hypertensive rat.

  1990cited by this paper
• Noradrenaline and cardiac hypertrophy in the rat: changes in morphology, blood pressure and ventricular performance.

  1989cited by this paper
• Remodelling of the heart in DOCA-salt hypertensive rats by propranolol and by an alpha-2 agonist, rilmenidine

  1989cited by this paper
• Cilazapril prevents the development of cardiac hypertrophy and the decrease of coronary vascular reserve in spontaneously hypertensive rats.

  1988cited by this paper
• Effects of arterial vasodilators on cardiac hypertrophy and sympathetic activity in rats.

  1988cited by this paper
• The spectrum of left ventricular hypertrophy in a general population sample: the Framingham Study.

  1987cited by this paper
• Time-course of changes in cardiac hypertrophy and pressor mechanisms in two-kidney, one clip hypertensive rats during treatment with minoxidil, enalapril or after uninephrectomy.

  1987cited by this paper
• Heart and vessel hypertrophy in hypertension: possibilities of regression.

  1987cited by this paper
• Left ventricular mass and fluid compartmentalization in Wistar-Kyoto and spontaneously hypertensive rats fed high- or low-sodium diet.

  1986cited by this paper
• Cardiac dimensions in spontaneously hypertensive rats following different modes of blood pressure reduction by antihypertensive treatment.

  1986cited by this paper
• Cardiac mass and peripheral vascular structure in hydralazine-treated spontaneously hypertensive rats.

  1985cited by this paper
• Regression of cardiac hypertrophy after therapy in animal hypertension.

  1985cited by this paper
• Non-invasive assessment of left ventricular anatomy and function in hypertensive patients following successful treatment of hypertension with the beta-adrenergic blocking drug atenolol

  1985cited by this paper
• The influence of sympathetic nervous activity on regression of cardiac hypertrophy.

  1985cited by this paper
• Does norepinephrine play a central causative role in the process of cardiac hypertrophy?

  1985cited by this paper
• Intrarenal beta-receptor and renal baroreceptor interaction in the control of the renin response to transient reduction of the renal perfusion pressure in man.

  1985cited by this paper
• Hyperplastic growth response of vascular smooth muscle cells following induction of acute hypertension in rats by aortic coarctation.

  1985cited by this paper
• Altered calcium handling in experimental pressure-overload hypertrophy in the ferret.

  1985cited by this paper
• Left ventricular mass and function before and after antihypertensive treatment.

  1983cited by this paper
• Electrocardiographic Aspects of Left Ventricular Hypertrophy

  1983cited by this paper
• Effect of methyldopa, clonidine, and hydralazine on cardiac mass and haemodynamics in Wistar Kyoto and spontaneously hypertensive rats.

  1982influential reference
• Is arterial pressure the sole factor responsible for hypertensive cardiac hypertrophy?

  1979cited by this paper
• Cardiac Hypertrophy in Spontaneously Hypertensive Rats

  1974cited by this paper

• Inhibition of GTPase Rac1 expression by vitamin D mitigates pressure overload-induced cardiac hypertrophy

  2021cites this paper
• Thymoquinone ameliorates pressure overload‐induced cardiac hypertrophy by activating the AMPK signalling pathway

  2021cites this paper
• Cannabinoid signaling modulation through JZL184 restores key phenotypes of a mouse model for Williams–Beuren syndrome

  2021cites this paper
• Molecular and Cellular Mechanisms Associated with Effects of Molecular Hydrogen in Cardiovascular and Central Nervous Systems

  2020cites this paper
• Imine stilbene analog ameliorate isoproterenol-induced cardiac hypertrophy and hydrogen peroxide-induced apoptosis.

  2020cites this paper
• Gentisic acid attenuates pressure overload‐induced cardiac hypertrophy and fibrosis in mice through inhibition of the ERK1/2 pathway

  2018cites this paper
• Protective effect of hydrogen-rich saline on pressure overload-induced cardiac hypertrophyin rats: possible role of JAK-STAT signaling

  2018cites this paper
• Therapeutic efficacy of phentolamine in the management of severe hand, foot and mouth disease combined with pulmonary edema

  2017cites this paper
• Resveratrol Ameliorates Cardiac Hypertrophy by Down‐regulation of miR‐155 Through Activation of Breast Cancer Type 1 Susceptibility Protein

  2016cites this paper
• Non-invasive assessment of cardiac function in a mouse model of renovascular hypertension

  2013cites this paper
• CARDIAC HYPERTROPHY: A REVIEW ON PATHOGENESIS AND TREATMENT

  2012cites this paper
• Quinapril

  2012cites this paper
• Perindopril

  2012cites this paper
• The Effect of Surgical Weight Reduction on Left Ventricular Structure and Function in Severe Obesity

  2010cites this paper
• UNIVERSIDAD NACIONAL DE TRUJILLO

  2010cites this paper
• Iptakalim: a new or just another KCO?

  2009cites this paper
• K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.

  2009cites this paper
• Efectividad de Losartan comparado con Enalapril administrados durante tres meses en la reducción del índice de performance miocárdio de pacientes hipertensos.

  2008cites this paper
• Selective cardiac neuroadrenergic abnormalities in hypertensive patients with left ventricular hypertrophy.

  2007cites this paper
• La protección cardíaca como estrategia prioritaria de prevención cardiovascular en hipertensión arterial

  2005cites this paper
• La protección cardíaca es la estrategia prioritaria de prevención cardiovascular en hipertensión arterial

  2004cites this paper
• Eficacia del uso de bisoprolol con hidroclorotiazida en la educción de la masa del ventrículo izquierdo en pacientes con hipertensión arterial en comparación con el uso del enalapril

  2004cites this paper
• Comparative Study of the Antihypertensive Activity of Marrubium Vulgare and of the Dihydropyridine Calcium Antagonist Amlodipine in Spontaneously Hypertensive Rat

  2004cites this paper
• Amlodipine decreases fibrosis and cardiac hypertrophy in spontaneously hypertensive rats: persistent effects after withdrawal.

  2004cites this paper
• Cardiac‐specific overexpression of a high Ca2+ affinity mutant of SERCA2a attenuates in vivo pressure overload cardiac hypertrophy

  2003cites this paper
• Value of rilmenidine therapy and its combination with perindopril on blood pressure and left ventricular hypertrophy in patients with essential hypertension (VERITAS)

  2003cites this paper
• Pharmacological characteristics of the novel antihypertensive drug, iptakalim hydrochloride, and its molecular mechanisms

  2003cites this paper
• Left ventricular hypertrophy: virtuous intentions, malign consequences.

  2003cites this paper
• Lacidipine

  2003cites this paper
• Redefining the roles of p38 and JNK signaling in cardiac hypertrophy: dichotomy between cultured myocytes and animal models.

  2003cites this paper
• Cardiac and renal effects of standard versus rigorous blood pressure control in autosomal-dominant polycystic kidney disease: results of a seven-year prospective randomized study.

  2002cites this paper
• QuinaprilUpdate of its Pharmacology and Therapeutic Use in Cardiovascular Disorders

  2002cites this paper
• Calcineurin Enhances MAPK Phosphatase-1 Expression and p38 MAPK Inactivation in Cardiac Myocytes*

  2001cites this paper
• Vitamin C and quinapril abrogate LVH and endothelial dysfunction in aortic-banded guinea pigs.

  2001cites this paper
• PerindoprilReview of Its Use in Hypertension

  2001cites this paper
• Normalisation of blood pressure in hypertensive TGR(mREN2)27 rats by amlodipine vs. enalapril: effects on cardiac hypertrophy and signal transduction pathways

  2000cites this paper